Enzyme Finance vs Index Coop: funds or leverage? (2026)

Enzyme Finance and Index Coop both operate in DeFi, but they serve different jobs. Enzyme is infrastructure for creating and administering tokenized funds, running curated on-chain strategies, and offering options through Myso. Its Onyx product is aimed at issuers, while Blue is for managers running strategies across protocols. Index Coop packages exposure into tokens: its products automate rebalancing for leveraged positions, and Smart Loops use automated yield strategies.

That distinction matters more than their shared “Indexes” category. Enzyme is the closer fit if you are building or choosing a managed fund or strategy. Index Coop is the more direct fit if you want a token representing automated leveraged exposure without manually managing a loan position. Neither product removes investment risk: Enzyme users face manager and strategy risks, while Index users face leverage, market and external-protocol risks.

Neither project publishes a complete schedule of user-facing fees here. Enzyme directs Onyx issuers to its pricing page, and the fees for individual Enzyme vaults are not specified. Vault managers may set management or performance fees, so investors should check a vault’s terms before depositing. Network gas fees also apply.

Index Coop does not state management, mint or redeem fee levels. It highlights financing costs, or cost of carry, for leveraged products. Its homepage gives a project-reported comparison of 10.02% for a 3x BTC long against 63.34% for perps funding, but that is a point-in-time figure and changes with lending-market rates. Gas and DEX slippage add to costs. Treat the comparison as an illustration, not a guaranteed rate or a forecast of future savings. For either protocol, check the specific product’s current terms before committing funds.

Both protocols carry smart-contract risk, and the listed audit counts need context. Enzyme has two audits listed; the auditor names, scope and dates are not published here. Enzyme also says it has SOC 2 certification and more than eight years of operation, but those points do not remove risk in a particular vault. A vault can expose users to its manager’s decisions and to third-party protocols. Compliance features such as whitelisting and transaction monitoring do not make an individual fund legally compliant.

Index Coop also has two audits listed, while the project says 8+ audits are complete, its contracts are open source and it runs an ongoing bug bounty. Its products still depend on external lending markets and DEX liquidity. Automated safeguards do not prevent losses: high leverage can magnify drawdowns, and a leveraged token may lose most of its value. Review product terms and risks before using either protocol.

Enzyme supports Ethereum, Polygon and Arbitrum; Onyx also lists Rayls and Canton coverage. Index Coop supports Ethereum, Arbitrum and Base. Both have Ethereum and Arbitrum in common, while Polygon is unique to Enzyme’s listed chains and Base to Index Coop’s. Availability can differ by product, so confirm the network for the specific fund or token you intend to use.

Enzyme’s reported TVL is about $94.1 million, compared with about $14.0 million for Index Coop. TVL indicates assets held in the protocol, not a guarantee of safety or the amount you can trade at a particular price. Index Coop also warns that liquidity for large trades may be limited; its homepage shows about $20 million in total exposure. Enzyme’s native token is MLN, and Index Coop’s is INDEX. The presence of a token does not mean it is required for every product or that it will appreciate.

Choose Enzyme if you are an issuer or asset manager seeking tools for tokenized funds, white-label interfaces, compliance workflows or managed on-chain strategies. It also offers a wider product mix, including Myso options. Its institutional focus and legacy Blue interface may be less straightforward for casual DeFi users, and pricing requires checking the relevant product or vault.

Choose Index Coop if you want automated leverage tokens or yield-looping products and understand the risk of amplified losses. Its automated rebalancing can spare holders from manually managing a loan position, but it does not make leverage safe. Index Coop’s restricted-token terms also exclude U.S. persons and people in jurisdictions where an offer is unlawful. If you are unsure whether you are eligible, check the terms and local law rather than attempting to bypass restrictions. For users seeking a managed fund platform rather than leveraged exposure, Enzyme is the clearer match.